Efficacy of fumagillin bicyclohexylamine on experimental corneal neovascularization in rat model

International Ophthalmology
M Fatih AşulaF Ulviye Yigit

Abstract

Fumagillin has been previously used to treat corneal microsporidial keratitis and also identified as an angiogenesis inhibitor. This study aimed to evaluate efficacy of fumagillin bicyclohexylamine on the rat model of corneal neovascularization induced by silver nitrate cauterization. Twenty-four Albino Wistar rats (n = 24) were divided into three groups. Following silver nitrate-induced corneal injury, eyes in Group 1 received one drop of 5 mg/mL topical fumagillin bicyclohexylamine four times daily for 10 days. Group 2 received subconjunctival injection of 0.1 mL fumagillin bicyclohexylamine (2.5 mg/mL) on day 1 and day 5. Group 3 received artificial tears and lubricants four times daily for 10 days as control. On day 10, animals were sacrificed. Corneal specimens were obtained and prepared to assess vascular endothelial growth factor (VEGF-C) levels and corneal angiogenic microvessel density. There was no significant difference in VEGF-C levels between the groups (P = 0.994). Assessment of angiogenic microvessel density for peripheral corneal zone also did not reveal significant difference between the groups (P = 0.113). However, mean vascular density in Group 1 and Group 2 was significantly higher for both midperipheral and...Continue Reading

References

Mar 1, 1992·Archives of Ophthalmology·R M LipmanR L Hendricks
Mar 15, 1993·American Journal of Ophthalmology·M C DiesenhouseR T Bryan
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·E C GriffithJ O Liu
Dec 14, 1999·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·A M JoussenB Kirchhof
Aug 17, 2001·Current Opinion in Ophthalmology·J H ChangD T Azar
Jan 26, 2002·Journal of Biomedical Science·Pent ZhangPeter K Chiang
Jun 21, 2002·The New England Journal of Medicine·Jean-Michel MolinaUNKNOWN Agence Nationale de Recherches sur le SIDA 090 Study Group
Feb 23, 1951·Science·M C McCOWENJ F LAWLIS
Jan 18, 1952·Science·H KATZNELSON, C A JAMIESON
Jan 18, 1952·Science·J H KILLOUGHR C SMITH
Aug 18, 2005·BMC Ophthalmology·Geeta K VemugantiShashi Singh
Sep 1, 2007·Clinical & Experimental Ophthalmology·Meredith ReginaRoberta Gausas
Sep 23, 2008·Transplant Infectious Disease : an Official Journal of the Transplantation Society·F LanternierO Lortholary
Sep 25, 2008·Acta Ophthalmologica·Shiqi LingZuguo Liu
Oct 19, 2010·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Wenru SuDan Liang
Jun 21, 2015·Biochemical and Biophysical Research Communications·Takayuki KannoHarutaka Katano

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.